image
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 23.93
0.642 %
$ 1.14 B
Market Cap
7.68
P/E
BALANCE SHEET
1.58 B ASSETS
4.27%
845 M LIABILITIES
-3.24%
732 M EQUITY
14.53%
BALANCE SHEET DECOMPOSITION
Balance Sheet Amphastar Pharmaceuticals, Inc.
image
Current Assets 534 M
Cash & Short-Term Investments 222 M
Receivables 138 M
Other Current Assets 174 M
Non-Current Assets 1.04 B
Long-Term Investments 11 M
PP&E 345 M
Other Non-Current Assets 688 M
14.05 %8.75 %11.06 %21.85 %43.60 %Total Assets$1.6b
Current Liabilities 174 M
Accounts Payable 30.5 M
Short-Term Debt 7.04 M
Other Current Liabilities 136 M
Non-Current Liabilities 671 M
Long-Term Debt 644 M
Other Non-Current Liabilities 27.9 M
3.61 %16.12 %76.14 %3.30 %Total Liabilities$845.2m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 151.6 144.3 156.1 126.4 92.6 73.7 86.3 65.6 72.4 66.1 67.8 53.6 50.2
Short Term Investments 70.0 112.5 19.7 10.3 13.0 11.7 2.8 2.6 0.5 1.3 1.5 0 0
Receivables 138.0 114.9 88.8 78.8 66.0 45.4 52.2 36.0 26.8 33.2 22.9 24.6 38.3
Inventory 153.7 105.8 103.6 92.8 96.8 110.5 69.3 63.6 79.8 70.7 82.3 69.9 51.4
Other Current Assets 20.6 12.0 17.7 9.8 11.2 14.0 9.7 19.9 4.7 6.0 25.0 24.9 25.8
Total Current Assets 534.1 489.6 378.3 318.1 279.7 255.2 220.3 187.8 184.1 175.9 198.0 173.0 165.7
PP&E 344.6 315.6 264.6 271.5 280.7 253.5 210.4 185.3 152.9 142.2 138.3 116.6 107.4
Intangible Assets 587.6 610.1 34.2 35.6 36.7 37.5 38.3 40.7 46.3 36.2 38.1 39.9 42.1
Goodwill 3.0 3.2 3.1 3.3 3.9 3.6 4.0 4.5 4.0 3.7 4.5 0.3 0.3
Long Term Investments 11.0 15.2 2.4 4.0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 26.0 25.9 20.9 16.7 5.2 11.2 9.9 8.7 9.4 4.7 3.6 2.9 2.0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 1 577.5 1 512.9 742.0 671.5 631.2 587.0 513.6 454.7 427.7 390.1 389.4 338.7 317.5
LIABILITIES
Accounts Payable 30.5 25.4 20.5 22.2 24.4 25.1 31.3 16.6 19.9 13.9 10.2 20.4 17.7
Short Term Debt 7.0 4.3 9.1 8.2 19.0 14.1 18.2 6.3 5.4 10.9 7.6 22.1 22.1
Other Current Liabilities 134.5 194.0 60.7 64.3 67.8 48.8 56.1 40.9 27.6 31.4 27.7 19.4 16.7
Total Current Liabilities 173.8 225.4 94.9 103.8 112.2 90.0 106.8 67.2 60.6 60.0 62.6 65.4 60.1
Long Term Debt 643.5 619.3 96.5 99.5 51.6 55.7 32.0 40.8 32.4 30.2 36.1 10.1 15.9
Deferred Tax Income 7.0 0 7.4 7.1 5.5 4.3 1.4 2.2 2.3 0.5 6.3 7.2 3.2
Other Liabilities 20.9 28.8 21.8 22.2 17.9 12.9 9.4 7.9 4.0 3.2 5.6 2.0 1.5
Total Liabilities 845.2 873.5 213.3 226.0 182.5 159.4 149.2 117.3 98.5 94.6 107.5 87.2 84.0
EQUITY
Common Stock 6 K 6 K 6 K 6 K 5 K 5 K 5 K 5 K 5 K 5 K 4 K 4 K 4 K
Retained Earnings 568.8 409.3 271.7 180.3 117.8 116.4 67.5 76.2 70.9 60.3 63.1 73.8 61.9
Other Accumulative Comprehensive Income/Loss (9.2) (8.5) (8.6) (6.8) (3.7) (4.7) (4.0) (2.1) (4.7) (2.5) (1.7) 0 0
Total Equity 732.3 639.4 528.7 445.5 448.7 427.5 364.4 337.3 329.3 295.5 281.9 251.5 233.4
Total Liabilities and Equity 1 577.5 1 512.9 742.0 671.5 631.2 587.0 513.6 454.7 427.7 390.1 389.4 338.7 317.5
SHARES OUTSTANDING
Common Shares Outstanding 48.4 48.3 48.6 47.8 47.0 47.0 46.4 46.1 45.4 45.0 42.0 8.0 8.0 8.0